COA provides software products for accounting and budgeting, data analysis, business intelligence (including patient pathways), compliance, billing, executive dashboard, HR, payroll, procurement, document management and BPO services.
The acquisition is expected to strengthen ACS's position within the healthcare and public-sector markets; provides access to key decision makers, creating significant opportunities for cross selling both ACS and COA products.
Vin Murria, CEO of ACS Group, said: “This is an excellent earnings-enhancing acquisition that significantly strengthens our position in the healthcare and public sector markets. It also brings us direct engagement with senior decision makers who need to deliver the kinds of efficiency savings that our combined product set can offer.
“There are substantial opportunities to cross sell our existing healthcare products into new markets while many of our existing healthcare clients could benefit from management tools in the COA product suite. Furthermore, it gives us a substantial and profitable commercial arm with a blue-chip client base that we will combine with our existing commercial arm. As we approach the end of ACS's financial year, I am pleased to report that we continue to trade in line with market expectations.”
Will ACS benefit with the acquisition?
Have your say and discuss with your peers on the InfoGrok community.
Participate by posting your comments now.
User Comments